생검 기기 시장 규모, 점유율, 성장 분석 : 제품별, 가이던스 기술별, 용도별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Biopsy Devices Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.58 Billion in 2025 to USD 24.47 Billion by 2033, growing at a CAGR of 14% during the forecast period (2026-2033).

The biopsy devices market is driven by the increasing prevalence of various cancers and advancements in technological integration. As a critical surgical method for diagnosing diseases like cancer and coeliac disease, the demand for specialized biopsy instruments is robust, particularly for organ biopsies of the liver, kidneys, and lungs. The incorporation of advanced imaging technologies such as CT scans, MRIs, and ultrasound enhances the precision and minimizes the invasiveness of biopsy procedures. Emerging methods like 3D optical and MRI-targeted biopsies are gaining traction, supporting the trend towards more accurate diagnostics. However, challenges remain, including the high cost of biopsy equipment and a shortage of trained professionals in developing regions, which can impede market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopsy Devices Market Segments Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Biopsy Devices Market

The biopsy devices market is largely propelled by the rising occurrence of cancer worldwide. As cancer rates escalate, the demand for accurate and early diagnostic tools intensifies, highlighting the necessity for timely intervention in patient care. This increasing requirement for biopsies fuels the advancement and adoption of innovative biopsy devices, thus driving market growth. The urgency for effective diagnostics and improved treatment options creates a flourishing environment for the development of advanced technologies in this sector, thereby enhancing the overall landscape of biopsy device offerings and their utilization in medical practices.

Restraints in the Biopsy Devices Market

The growth of the biopsy devices market is significantly impeded in numerous developing regions due to restricted access to cutting-edge biopsy technologies. Economic challenges coupled with underdeveloped healthcare infrastructures limit both the availability and adoption of modern biopsy instruments. This lack of accessibility not only affects the immediate use of such devices but also influences their overall market expansion, as healthcare providers in these areas face barriers that prevent the integration of advanced diagnostic tools. Consequently, these factors create a notable restraint in the progression and potential of the biopsy devices market in these underserved locations.

Market Trends of the Biopsy Devices Market

The Biopsy Devices market is witnessing a notable trend towards the adoption of image-guided biopsy techniques, such as ultrasound and CT scan guidance, due to their enhanced accuracy and real-time imaging capabilities. This technological advancement is not only improving diagnostic precision but also positively impacting patient outcomes. As healthcare providers increasingly recognize the benefits of these innovative methods, the demand for advanced biopsy equipment is expected to surge. This shift towards minimally invasive procedures, combined with a growing emphasis on precise diagnostics in oncology and other fields, is propelling growth and transforming the biopsy device landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Customer & Buying Criteria Analysis
• Technology Analysis
• Case Study Analysis
• Pricing Analysis

Biopsy Devices Market, By Product

• Market Overview
• Liquid Biopsy Instruments
• Needle-Based Biopsy Instruments
  • Core Biopsy Devices
  • Core Biopsy Needles
  • Core Biopsy Guns
  • Aspiration Biopsy Needles
  • Vacuum-Assisted Biopsy Devices
  • Vacuum-Assisted Biopsy Systems
  • Vacuum-Assisted Biopsy Needles
• Procedure Trays
• Localization Wires
• Biopsy Tables
• Biopsy Forceps
  • General Biopsy Forceps
  • Hot Biopsy Forceps
• Other Products

Biopsy Devices Market, By Guidance Technique

• Market Overview
• Non-Image-Guided Biopsy
• Image-Guided Biopsy
  • Ultrasound-Guided Biopsy
  • Stereotactic-Guided Biopsy
  • Mri-Guided Biopsy
  • Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

• Market Overview
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Prostate Cancer
• Bone Marrow Biopsy
• Other Applications

Biopsy Devices Market, By End User

• Market Overview
• Hospitals & Breast Care Centers
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Other End Users

Biopsy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inrad, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conmed Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Summit Medical LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill-Rom Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gallini S.R.L (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transmed7, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSK Laboratory International (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DR. Japan Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IZI Medical Products (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advin Health Care (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments